Literature DB >> 11520655

Test validity of periodic liver function tests in a population of Japanese male bank employees.

E Yano1, K Tagawa, K Yamaoka, M Mori.   

Abstract

The validity (sensitivity and specificity) of annual liver function tests, determined by assaying blood levels of aspartate aminotransferase, alanine aminotransferase and gammaglutamyl transpeptidase, was evaluated using the results of health checkups of male bank workers. The specificity of each liver function test to detect persons with fatty liver, excess alcohol users, and hepatic virus carriers, diagnosed respectively by ultrasound, detailed inquiry, and virus marker tests, was always higher than 80%, except for alanine aminotransferase in excess alcohol users (63.5%). However, the highest sensitivity to detect virus carriers was alanine aminotransferase to detect HCV antibody-positive workers, but it was only 45.5%. The highest sensitivity of the liver function tests to detect excess alcohol users in obese subjects was only 33.3%. The highest sensitivity by liver function tests to detect fatty liver was 35.7% which was inferior to that of the body mass index. These results indicate that the liver function tests mandated in the workplace periodic health checkups in Japan exhibit very low sensitivity for the detection of any of the proposed target clinical conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520655     DOI: 10.1016/s0895-4356(01)00355-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.

Authors:  Lei Shen; Jian-Gao Fan; Yan Shao; Min-De Zeng; Jun-Rong Wang; Guo-Hao Luo; Ji-Qiang Li; Si-Yao Chen
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Leon A Adams; Paul Angulo; Keith D Lindor
Journal:  CMAJ       Date:  2005-03-29       Impact factor: 8.262

3.  Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation.

Authors:  Chiadi E Ndumele; Khurram Nasir; Raquel D Conceiçao; Jose A M Carvalho; Roger S Blumenthal; Raul D Santos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-05-05       Impact factor: 8.311

4.  Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Authors:  Savino Bruno; Patrick Maisonneuve; Paola Castellana; Nicole Rotmensz; Sonia Rossi; Marco Maggioni; Marcello Persico; Alberto Colombo; Franco Monasterolo; Donata Casadei-Giunchi; Franco Desiderio; Tommaso Stroffolini; Virgilio Sacchini; Andrea Decensi; Umberto Veronesi
Journal:  BMJ       Date:  2005-03-03

Review 5.  Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.

Authors:  Zaki A Sherif; Armana Saeed; Shima Ghavimi; Seyed-Mehdi Nouraie; Adeyinka O Laiyemo; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

6.  A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis.

Authors:  Ashvin Bashyam; Chris J Frangieh; Siavash Raigani; Jeremy Sogo; Roderick T Bronson; Korkut Uygun; Heidi Yeh; Dennis A Ausiello; Michael J Cima
Journal:  Nat Biomed Eng       Date:  2020-11-30       Impact factor: 25.671

7.  Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.

Authors:  David T Arnold; Louise M Bentham; Ruth P Jacob; Richard J Lilford; Alan J Girling
Journal:  BMC Fam Pract       Date:  2011-03-03       Impact factor: 2.497

8.  Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice.

Authors:  Fenni Rusli; Joris Deelen; Evi Andriyani; Mark V Boekschoten; Carolien Lute; Erik B van den Akker; Michael Müller; Marian Beekman; Wilma T Steegenga
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

9.  Evaluation of quantitative liver function tests in HIV-positive patients under anti-retroviral therapy.

Authors:  M Miller; A Kahraman; B Ross; M Beste; Guido Gerken
Journal:  Eur J Med Res       Date:  2009-09-01       Impact factor: 2.175

10.  Costs and cost-effectiveness of different follow-up schedules for detection of occupational hepatitis C virus infection.

Authors:  S Deuffic-Burban; D Abiteboul; F Lot; M Branger; E Bouvet; Y Yazdanpanah
Journal:  Gut       Date:  2008-09-29       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.